secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0001628280-25-001867
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 2.02, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Salarius Pharma reports $2.4M preliminary cash; sells 141K shares for $493.5K
-----------------------------------------------------------------------------

- Cash and cash equivalents estimated at $2.4M as of Dec 31, 2024 (preliminary, unaudited).
- Issued 141,000 shares at $3.50/share to C/M Capital Master Fund LP for $493,500.
- Also issued 1,410 commitment shares to the same investor.
- Exemption from registration under Section 4(a)(2) and Regulation D claimed.
- Sale followed written notice under Dec 12, 2024 Securities Purchase Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000162828025001867/0001628280-25-001867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000162828025001867/flks-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-001867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer